Active ingredient
Talazoparib
12 finished FDA listings contain Talazoparib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- TALAZOPARIB, TALAZOPARIB TOSYLATE
- Dosage forms
- Capsule, Capsule, Liquid Filled
- Routes
- Oral
- Manufacturers / labelers
- 2
- Strengths listed
- .1 mg/1 · .25 mg/1 · .35 mg/1 · .5 mg/1 · .75 mg/1 · 1 mg/1
- Brand names in FDA listings
- Talzenna
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2099704
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 211651 | PFIZER | 2018-10-16 | 4 |
| NDA 217439 | PFIZER | 2024-03-07 | 8 |
Official labeling on DailyMed
- TALZENNA (TALAZOPARIB) CAPSULE [U.S. PHARMACEUTICALS] · version 10 · 2026-06-03
- TALZENNA (TALAZOPARIB) CAPSULE, LIQUID FILLED [PFIZER LABORATORIES DIV PFIZER INC] · version 4 · 2026-04-13
- TALZENNA (TALAZOPARIB) CAPSULE, LIQUID FILLED [U.S. PHARMACEUTICALS] · version 1 · 2026-02-26
- TALZENNA (TALAZOPARIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] · version 19 · 2025-12-19
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.